Suzhou Basecare Medical Corporation Limited (HKG:2170)
Hong Kong · Delayed Price · Currency is HKD 1.350
0.00 (0.00%)
Sep 9, 2026, 3:48 PM HKT
HKG:2170 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 260.68 | 233.27 | 299.11 | 207.98 | 140.9 | 107.3 | |
Revenue Growth | -5.45% | -22.01% | 43.82% | 47.60% | 31.32% | 32.29% |
Cost of Revenue | 120.93 | 109.66 | 162.89 | 116.63 | 81.37 | 56.15 |
Gross Profit | 139.75 | 123.61 | 136.22 | 91.35 | 59.53 | 51.15 |
Selling, General & Admin | 214.6 | 231.97 | 276.39 | 209.3 | 161.5 | 114.64 |
Research & Development | 82.34 | 106.42 | 135.26 | 129.57 | 119.77 | 73.71 |
Other Operating Expenses | -4.86 | -3.99 | -7.63 | -5.85 | -5.7 | -4.82 |
Operating Expenses | 284.78 | 334.4 | 404.01 | 333.02 | 275.57 | 183.53 |
Operating Income | -145.03 | -210.79 | -267.79 | -241.67 | -216.04 | -132.38 |
Interest Expense | -11.33 | -13.12 | -9.37 | -2.61 | -0.5 | -1.26 |
Interest & Investment Income | 8.94 | 11.8 | 25.27 | 38.51 | 23.62 | 18.2 |
Currency Exchange Gain (Loss) | -10.92 | -4.37 | 8.66 | 11.86 | 62.91 | -10.31 |
EBT Excluding Unusual Items | -158.34 | -216.47 | -243.24 | -193.92 | -130.01 | -125.75 |
Gain (Loss) on Sale of Investments | -20.03 | -10.72 | 2.9 | -2.4 | 3.4 | - |
Pretax Income | -178.37 | -227.19 | -240.34 | -196.32 | -126.61 | -125.75 |
Income Tax Expense | -4.36 | -3.74 | -3.13 | -2.97 | 6.01 | 18.33 |
Earnings From Continuing Operations | -174.01 | -223.46 | -237.21 | -193.35 | -132.63 | -144.08 |
Earnings From Discontinued Operations | - | - | - | - | 9.12 | - |
Net Income to Company | -174.01 | -223.46 | -237.21 | -193.35 | -123.51 | -144.08 |
Minority Interest in Earnings | -0.02 | - | 0.18 | 1.66 | 0.84 | 0.43 |
Net Income | -174.03 | -223.46 | -237.03 | -191.69 | -122.66 | -143.65 |
Net Income to Common | -174.03 | -223.46 | -237.03 | -191.69 | -122.66 | -143.65 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 274 | 274 | 274 | 274 | 274 | 265 |
Shares Outstanding (Diluted) | 274 | 274 | 274 | 274 | 274 | 265 |
Shares Change | - | - | - | - | 3.09% | 54.34% |
EPS (Basic) | -0.64 | -0.82 | -0.87 | -0.70 | -0.45 | -0.54 |
EPS (Diluted) | -0.64 | -0.82 | -0.87 | -0.70 | -0.45 | -0.54 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -253.45 | -322.41 | -371.44 | -317.22 | -226.75 |
Free Cash Flow Per Share | - | -0.93 | -1.18 | -1.36 | -1.16 | -0.85 |
Gross Margin | 53.61% | 52.99% | 45.54% | 43.92% | 42.25% | 47.67% |
Operating Margin | -55.64% | -90.36% | -89.53% | -116.20% | -153.33% | -123.38% |
Profit Margin | -66.76% | -95.79% | -79.25% | -92.17% | -87.06% | -133.88% |
Free Cash Flow Margin | - | -108.65% | -107.79% | -178.60% | -225.14% | -211.33% |
EBITDA | -99.5 | -166.99 | -237.6 | -227.18 | -210.59 | -129.5 |
EBITDA Margin | -38.17% | -71.59% | -79.44% | -109.23% | -149.46% | -120.69% |
D&A For EBITDA | 45.53 | 43.79 | 30.19 | 14.49 | 5.45 | 2.89 |
EBIT | -145.03 | -210.79 | -267.79 | -241.67 | -216.04 | -132.38 |
EBIT Margin | -55.64% | -90.36% | -89.53% | -116.20% | -153.33% | -123.38% |